ImmunoGen, Inc.
METHODS OF TREATMENT USING ANTI-CD123 IMMUNOCONJUGATES
Last updated:
Abstract:
Methods of administering immunoconjugates that bind to CD123 are provided. The methods comprise administering an anti-CD123 immunoconjugate (e.g., IMGN632) to a subject in need thereof, for example, a patient with a hematologic malignancy, at a therapeutically effective dose regimen that results in treatment of the hematologic malignancy.
Status:
Application
Type:
Utility
Filling date:
30 Oct 2019
Issue date:
21 May 2020